tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KSPHF Stock Latest News

Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
Company AnnouncementsKissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
11d ago
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
PremiumCompany Announcements
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
1M ago
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
PremiumCompany Announcements
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
1M ago
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
PremiumCompany Announcements
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
1M ago
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
1M ago
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
PremiumCompany AnnouncementsKissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
3M ago
Kissei Pharmaceutical initiated with a Neutral at UBS
Premium
The Fly
Kissei Pharmaceutical initiated with a Neutral at UBS
3M ago
Kissei Pharmaceutical Adjusts Dividend Payment Date
Premium
Company Announcements
Kissei Pharmaceutical Adjusts Dividend Payment Date
3M ago
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
PremiumCompany Announcements
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
4M ago
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
PremiumCompany Announcements
Kissei Pharmaceutical Revises Financial Forecast with Positive Outlook
4M ago
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
PremiumCompany Announcements
Kissei Pharmaceutical Reports Financial Results with Increased Net Sales
4M ago
Kissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Kissei Pharmaceutical Co (KSPHF) Q2 Earnings Cheat Sheet
4M ago
Kissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
PremiumCompany AnnouncementsKissei Pharmaceutical’s Promising Phase III Study on Spinocerebellar Degeneration
4M ago
KSPHF
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
Premium
Company Announcements
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment
4M ago
KSPHF
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
Premium
Company Announcements
Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments
4M ago
KSPHF
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
PremiumCompany Announcements
Kissei Pharmaceutical’s Fostamatinib Study: A Potential Game-Changer for Chronic Thrombocytopenic Purpura
4M ago
KSPHF
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
PremiumCompany Announcements
Kissei Pharmaceutical’s Promising Phase II Trial for Parkinson’s Treatment
4M ago
KSPHF
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
PremiumCompany Announcements
Kissei’s Linzagolix Gains Marketing Approval in Taiwan
5M ago
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
PremiumCompany Announcements
Kissei Pharmaceutical Expands Linzagolix Reach with Canadian Licensing Deal
5M ago
Kissei Pharmaceutical Completes Sale of Investment Securities
PremiumCompany AnnouncementsKissei Pharmaceutical Completes Sale of Investment Securities
6M ago
Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
Premium
Company Announcements
Kissei Pharmaceutical Secures Licensing for TED Treatments in Japan
7M ago
Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income
Premium
Company Announcements
Kissei Pharmaceutical Revises Financial Forecast and Records Extraordinary Income
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >